← All organizations

Immuno US, Inc.

For profit

Also known as: Immuno-US

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Nov 2, 1999

Acquired by Baxalta → Shire → Takeda on Jun 1, 1997

Timeline

1990s

Jun 1, 1992
Immuno US, Inc.— Founded
Jun 1, 1997
Baxalta— Acquired By

2010s

Dec 3, 2018
Takeda— Now

Drugs by trial phase (5 distinct, 5 trials)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (5)

NCT00001056CollaboratorPhase 1Nov 2, 1999
NCT00000822CollaboratorPhase 1Nov 2, 1999
NCT00000633CollaboratorPhase 1Nov 2, 1999
NCT00000957CollaboratorPhase 1Nov 2, 1999
NCT00000968CollaboratorPhase 1Nov 2, 1999

Details

Founded: San Diego, CA, US Jun 1, 1992
Last known activity: Nov 2, 1999

Notes

unable to find founded date; may no longer exist- approved APIs and trial start dates prior to 2000